Mostrando 2 resultados de: 2
Filtros aplicados
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(1)
Fisiología humana(1)
Problemas sociales y servicios a grupos(1)
Salud y seguridad personal(1)
Origen
scopus(2)
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusDyslipidemia epidemiological behaviour in patients from the Endocrine and Metabolic diseases research Institute Dr. Félix Gómez at Universidad del Zulia, Venezuela
ArticleAbstract: Introduction: Dyslipidemias constitute an essential cardiovascular risk factor in the development ofPalabras claves:Cardiovascular disease, cholesterol, dyslipidemia, Lipoproteins, TriglyceridesAutores:Ávila A.G., De Diaz A.A., González M.C., Gotera J.L., Linares J.C., Mosquera-Sulbarán J.A., Valero N.J., Valmore BermúdezFuentes:scopus